This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Nephrotic Syndrome, Minimal Change
Information about Nephrotic Syndrome, Minimal Change: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Nephrotic Syndrome, Minimal Change
Most recent studies have shown that Nephrotic Syndrome, Minimal Change shares some biological mechanisms with edema, focal-glomerulosclerosis, glomerulonephritis, glomerulonephritis-membranoproliferative, glomerulonephritis-minimal-change, glomerulosclerosis-(disorder), iga-glomerulonephritis, kidney-diseases, kidney-failure, lipoid-nephrosis, lupus-erythematosus-systemic, lupus-nephritis, membranous-glomerulonephritis, nephritis, nephrotic-syndrome, proteinuria-of-undiagnosed-cause, renal-glomerular-disease, sclerosis, segmental-glomerulosclerosis.
Among the many pathways, these few ones have gauged particular interests from scientists studying Nephrotic Syndrome, Minimal Change, and have been seen in publications frequently: Cell Activation, Cell Adhesion, Cell Proliferation, Coagulation, Complement Activation, Diuresis, Dna Methylation, Excretion, Glomerular Filtration, Hypersensitivity, Immune Response, Inflammatory Response, Localization, Methylation, Pathogenesis, Platelet Aggregation, Regeneration, Secretion, T Cell Activation, Transport
Quite a number of genes have been found to play important roles in Nephrotic Syndrome, Minimal Change, such as ACE, ACTN4, ALB, C3, CA9, GNL3, GYPA, HLA-DQA1, IL2, IL4, IL6, KRAS, NBAS, NOD2, NPHS1, RAPGEF5, SCN7A, SPP1, TNF, VEGFA. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.